Article info
Hepatology
Original article
ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis
- Correspondence to Professor Claus Hellerbrand, Institute of Biochemistry, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen D-91054, Germany; claus.hellerbrand{at}fau.de
Citation
ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis
Publication history
- Received June 22, 2016
- Revised December 7, 2016
- Accepted December 8, 2016
- First published January 4, 2017.
Online issue publication
March 08, 2018
Article Versions
- Previous version (4 January 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/